BDBM224079 3-(6-{[(1r)-1- cyclobutylethyl]amino}- 8-[4-(1-hydroxy-1- methylethyl)pyridin-2- yl]-7-[(trans-4- methylcyclohexyl)methyl]- 7h-purin-2-yl)-1,2,4- oxadiazol-5(4h)-one::US9540377, 15.23

SMILES C[C@@H](Nc1nc(-c2noc(=O)[nH]2)nc2nc(-c3cc(C(C)(C)O)ccn3)n(C[C@H]3CC[C@H](C)CC3)c12)C1CCC1

InChI Key InChIKey=BTZRCQFBMZVPIW-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 224079   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 224079BDBM224079(US9540377, 15.23 | 3-(6-{[(1r)-1- cyclobutylethyl]...)
Affinity DataIC50: 4.75nMT: 2°CAssay Description:An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2018
Entry Details
US Patent